Canada markets open in 4 hours 56 minutes

Navidea Biopharmaceuticals, Inc. (NAVB)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0350-0.0070 (-16.67%)
At close: 03:22PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0.61
14.645
45.615
118.725
Cost of Revenue
50.036
184.947
0
1.048
Gross Profit
-49.426
-170.302
45.615
117.677
Operating Expenses
Research Development
5,093
5,970
5,142
4,930
Selling General and Administrative
5,037
7,962
7,450
6,695
Total Operating Expenses
10,130
13,881
12,106
10,829
Operating Income or Loss
-10,180
-14,051
-12,060
-10,711
Interest Expense
-
1,098
6.361
-
Total Other Income/Expenses Net
1,569
-27.939
351.885
-21.854
Income Before Tax
-8,607
-15,177
-11,715
-10,722
Income Tax Expense
-
0
16.043
0
Income from Continuing Operations
-8,607
-15,177
-11,731
-10,722
Net Income
-1,182
-15,177
-11,731
-10,722
Net Income available to common shareholders
-1,389
-17,215
-11,731
-11,386
Basic EPS
-0.08
-0.56
-0.40
-0.48
Diluted EPS
-0.08
-0.56
-0.40
-0.48
Basic Average Shares
53,347
30,902
29,344
23,896
Diluted Average Shares
53,347
30,902
29,344
23,896